Cardiovascular risk evaluation through heart rate variability analysis in psoriatic patients before and after 24 weeks of etanercept therapy: Prospective study

Conclusion
Treatment with etanercept in patients with moderate-to-severe psoriasis could affect cardiovascular autonomic regulation, and subsequently reduce cardiovascular risk.

Source: Journal of International Medical Research - September 27, 2016 Category: Research Authors: Potenza, C., Raimondi, G., Pampena, R., Proietti, I., Viola, G. L., Bernardini, N., Tolino, E., Zuber, S., Balduzzi, V., Scordamaglia, B., Skroza, N. Tags: Immuno-Mediated Diseases and Treatment Immunogenicity Source Type: research